The AI question no one wants to answer

The latest stories trending on MedCity News.

Editor's Pick

Top Story The Healthcare AI Question No One Wants to Answer At ViVE 2024, Tarun Kapoor — chief digital transformation officer at New Jersey-based Virtua Health — highlighted a conundrum he thinks may be the reason why AI hasn't been able to move the needle when it comes to solving the clinician shortage. Calling All Women's Health Startups Need more funding? Looking for new partnerships? This is your chance to get in front of healthcare's best industry experts and VCs. Apply to Pitch at INVEST 2024 May 21-22 in Chicago. Winners will receive a $20K branding advertising package. You don't want to miss this opportunity to share how your company is making a difference in biopharma oncology. Deadline to apply is approaching fast, Feb 29th. Apply Now

Featured News

At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice. What Omada Health Wouldn't Use AI For When it comes to behavior change support, humans are still better than AI, according to Dr. Carolyn Bradner Jasik, chief medical officer at Omada Health. Lose Fat, Not Muscle: Next Test for Lilly's Zepbound Pairs It With BioAge Drug In preclinical testing, combining BioAge Labs' experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans. Dentistry's Technological Revolution Is Transforming Patient Trust The way dentistry has embraced technological innovation to make patient care both safer and more comfortable serves as an example for the rest of the healthcare sector.

Resources

MedCity FemFwd: What Male Birth Control Means for Women's Health In this episode of MedCity FemFwd, we were joined by Régine Sitruk-Ware, a distinguished scientist at the Population Council's Center for Biomedical Research (CBR), and Chelsea Polis, senior scientist of epidemiology at CBR. Sitruk-Ware and Polis discuss what the development of a male birth control product could mean for women's health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe